氧化应激
小胶质细胞
神经炎症
星形胶质细胞
内分泌学
CD36
医学
内科学
Evolocumab公司
化学
药理学
神经胶质
丙二醛
胶质纤维酸性蛋白
冲程(发动机)
神经保护
炎症
细胞生物学
纽恩
活力测定
内大麻素系统
神经科学
体内
微泡
作者
Yan Li,Lianju Jing,Jiaqi Jiao,Gao Zhuqing,Jing Yin,Yao Cheng,Yujie Zhai,Junhong Guo,Yan‐Ying Fan
标识
DOI:10.1136/svn-2026-005579
摘要
Background Lipid droplet (LD) accumulation in glial cells during the subacute-chronic phases of stroke drives neuroinflammation and impedes neurological recovery. Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) effectively lower peripheral lipids, but whether they regulate cerebral lipid homeostasis and improve post-stroke rehabilitation remains unclear.Methods Using a mouse photothrombotic infarction model, mice received a single dose of evolocumab (PCSK9i) on days 1, 3 or 7 postinjury. Motor function was evaluated by grid-walking, cylinder and DigiGait tests. Dendritic plasticity, glial perilipin 2 (PLIN2, an LD marker), and ox-LDL levels were assessed by Golgi-Cox staining, immunofluorescence and ELISA. Oxidative stress and pro-inflammatory gene expression ( Il1b, Tnf and C3) were evaluated by malondialdehyde measurement and qPCR. Following ox-LDL exposure, LD accumulation, oxidative stress and the expression of Il1b, Tnf, C3 and S100a10 in BV2 microglia and primary astrocytes were assessed by BODIPY staining, dihydroethidium staining and qPCR. Conditioned medium collected from ox-LDL-exposed microglia and astrocytes after culture in ox-LDL-free medium was applied to HT22 neurons to assess indirect ox-LDL-mediated effects on neuronal viability and the expression of postsynaptic density protein 95 and synaptophysin. DiI-labelled ox-LDL (DiI-ox-LDL) was administered via tail-vein injection to trace its entry into peri-infarct tissue.Results Evolocumab administered at each tested time point facilitated motor recovery. Day 3 treatment enhanced dendritic plasticity and reduced peri-infarct glial LD accumulation, ox-LDL levels, oxidative stress and inflammatory responses. In vitro, ox-LDL induced glial LD accumulation, oxidative stress and inflammation, while conditioned media produced detrimental effect on HT22 neurons. In vivo tracing showed that DiI-ox-LDL crossed the disrupted blood–brain barrier and accumulated in peri-infarct microglia and astrocytes.Conclusion PCSK9i administered during the subacute phase of stroke promotes neurological recovery. This benefit may arise, at least in part, from suppressing ox-LDL-induced glial LD pathology, supporting its potential for post-stroke rehabilitation.
科研通智能强力驱动
Strongly Powered by AbleSci AI